Andrew I Flyak

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Molecular Dynamics Simulations

Palliative Care

Monoclonal Antibody

Hepatitis C Virus

Top Venues

Science translational medicine

California Institute of Technology

This page only lists publications with an associated author ORCID identifier.

Affiliation History

California Institute of Technology Aug 01 2016

United States

CRI Irvington Postdoctoral Scholar :: Biology and Biological Engineering

Publications

Clinton O Ogega, Nicole E Skinner, Andrew I Flyak, Kaitlyn E Clark, Nathan L Board, Pamela J Bjorkman, James E Crowe, Andrea L Cox, Stuart C Ray, Justin R Bailey
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS pathogens 18 (1) (2022)
Andrew I Flyak, Stormy E Ruiz, Jordan Salas, Semi Rho, Justin R Bailey, Pamela J Bjorkman
An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein. eLife 9 (2020)
Chad E Mire, Thomas W Geisbert, Viktoriya Borisevich, Karla A Fenton, Krystle N Agans, Andrew I Flyak, Daniel J Deer, Herta Steinkellner, Ognian Bohorov, Natasha Bohorova, Charles Goodman, Andrew Hiatt, Do H Kim, Michael H Pauly, Jesus Velasco, Kevin J Whaley, James E Crowe, Larry Zeitlin
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Science translational medicine 9 (384) (2017)